Skip to main content
Skip to footer

DynaMed and Micromedex with Watson logo

1:45

DynaMed and Micromedex with Watson

DynaMed and Micromedex with Watson combines DynaMed's extensive, expert-crafted content with the comprehensive drug information and AI capabilities of IBM Micromedex to provide the most useful answers to clinical questions.

DynaMed and Micromedex with Watson (DMX) give clinicians comprehensive disease and medication content curated using rigorous evidence-based editorial principles. Designed for the point of care, the solution combines clinical evidence and guidance from accredited experts. With intuitive personalization features, natural language drug search capabilities via the Watson Assistant, streamlined EHR integration, and a robust mobile experience, DMX makes it easy for clinicians to access the content they need when and where they need it. DMX offers a wide variety of content and tools, including evidence-based disease/conditions topics, drug topics, a drug interaction checker, an IV compatibility checker and much more.

Use Cases

  • A 72-year-old man presents to the emergency department (ED) with rhinorrhea, lightheadedness, and cough with purulent sputum. As part of the evaluation, an ECG is ordered that reveals a prolonged QT interval which the patient states have been present on prior ECGs. The ED physician diagnoses acute bronchitis and begins to prescribe azithromycin but pauses to check DynaMedex with Watson and queries Watson. The physician uses the voice to text feature on DynaMed and Micromedex app to ask Watson "What are the contraindications to azithromycin" and discovers it can prolong QT interval and result in torsade de pointes. The ED physician looks up acute bronchitis in DynaMedex with Watson and queries Watson again, asking, "Are there alternative treatments" and discovers that antibiotic therapy is not recommended in uncomplicated acute bronchitis. The patient is told to use over-the-counter guaifenesin, hydrate, and see his personal physician if not better in two weeks.

  • A 44-year-old man previously prescribed apixaban for a deep vein thrombosis two months earlier presents to the emergency department (ED) with acute shortness of breath and pleuritic chest pain. A pulmonary embolism (PE) is suspected, and a computerized tomogram pulmonary angiogram (CTPA) is performed, confirming the presence of a PE. The patient swears compliance with apixaban and the ED physician closely examines the patient's drug list for agents that might interact with apixaban but does not find any. He next searches DynaMed and Micromedex with Watson to explore what might have affected metabolism and discovers that CYP3A4 and p-glycoprotein inducers can decrease exposure to apixaban resulting in blood clots; one such agent listed was St. John's wart, an over-the-counter agent used by many for depression. Upon further questioning, the patient confirms he had begun to take this about two weeks prior. He was educated about this interaction and told to stop the St. John's wort.

  • A 70-year-old Black male presents to his primary care physician's office complaining of fatigue and lightheadedness. His pulse is irregularly irregular, and an ECG confirms the presence of atrial fibrillation. The physician uses DynaMed and Micromedex with Watson to calculate his CHA2DS-VASc score, which is 1. She reads in DynaMed and Micromedex with Watson topic on Thromboembolic Prophylaxis in Atrial Fibrillation that the decision to anticoagulate a male with this degree of stroke risk is controversial. She next uses DynaMed HAS-BLED calculator to assess his risk of bleeding should anticoagulation be initiated, which calculates to 2. After using DynaMed Decisions with the patient, a 3% chance of stroke in the next 5 years is determined, and the patient wishes to begin anticoagulation. The MD explains the modifiable risk factors to reduce the risk of bleeding, including avoiding nonsteroidal medication use and reducing alcohol consumption from the current 10 drinks a week to less than 8 per week. Apixaban is selected, and a check on "ask Watson" reveals that consumption of grapefruit juice can interact with this agent, and he is told not to ingest this from now on.

Available in These Countries

  • This solution is offered worldwide.

Supported Devices

  • Desktop
  • Tablet
  • SmartPhone

Version Details

Compatible with PowerChart

Key Features

Designed for Ease of Use

DynaMed and Micromedex with Watson's streamlined, user-friendly interface allows clinicians to find the information they need with speed and accuracy. Users can navigate content via the search box in up to 15 languages, browse by Specialties or Drugs A-Z and easily jump back into recently viewed and followed topics.

Easy to Digest Content

DynaMed and Micromedex with Watson topics are created with the time-crunched clinician in mind. Topics offer a sleek bulleted format to facilitate fast answers to questions at the point of care, comprehensive but intuitive navigation, quick links to the original evidence for deep dives and images and algorithms to support effective decision-making.

The Watson Assistant

Receive fast answers to medication questions with natural and conversational search capabilities. Enabled by Watson, DynaMed and Micromedex with Watson now uses AI to accelerate your access to drug information by bypassing the keyword search process in favor of natural language queries. This means you can type the way you talk into the Watson Assistant and get the answers you need.

CME and MOC Made Easy

DynaMed and Micromedex with Watson makes it easier than ever for users to earn CME and MOC credits. Users simply create a personal user account to earn CME and MOC credits for all their DynaMed and Micromedex with Watson usage. A personal user account also allows users to access DynaMed and Micromedex with Watson anytime, anywhere, and quickly revisit recently viewed and followed topics.

Take DynaMed and Micromedex with Watson On-The-Go

DynaMed and Micromedex with Watson provides users with a complimentary mobile app available on both iOS and Android devices, enabling users to access DynaMed anytime, anywhere.